Notably, up to 90% of aggressive early-onset PCa tumors appear to be ERG+, and ETS+ tumors have elevated AR expression and somatic alterations that are androgen-driven, including the expression of TMPRSS2-ETS fusions [8]. The gene discussed is ERG; the disease is posterior cortical atrophy.